Managing Intracranial Pressure Crisis

Abstract:

Viarasilpa provides a comprehensive review of current strategies for managing intracranial pressure (ICP) crises, emphasizing critical care management, ICP monitoring, neuromonitoring, and evidence-based therapeutic approaches. The review integrates protocols from the Brain Trauma Foundation (BTF), Seattle International Severe Traumatic Brain Injury Consensus Conference (SIBICC), and Consensus-based management protocol (CREVICE), advocating personalized, neuromonitoring-driven interventions to optimize cerebral perfusion and outcomes.

Key Insights:

1. Importance of ICP Monitoring: ICP monitoring provides essential real-time data, including ICP values, trends, waveforms, and cerebral perfusion pressure (CPP), significantly guiding individualized patient management during ICP crises.
2. Initial Critical Care Management: Patients at risk of ICP crises should receive immediate baseline care, including lung-protective mechanical ventilation, euvolemic fluid management, sedation, seizure prophylaxis, temperature and glycemic control, and maintaining appropriate mean arterial pressure (MAP) targets.
3. ICP-Lowering Therapies: Initial ICP reduction therapies recommended include osmotic agents (mannitol or hypertonic saline), dexamethasone for edema due to tumors or abscesses, external ventricular drainage, and surgical decompression when clinically indicated.
4. Escalation Protocols Without ICP Monitoring (CREVICE): In the absence of ICP monitors, escalation of therapy intensity is guided by clinical neuroworsening and imaging findings, progressing through scheduled hyperosmolar therapy, continuous hypertonic saline infusions, hyperventilation, deep sedation, barbiturate coma, mild hypothermia, and decompressive craniectomy.
5. Escalation Protocols With ICP Monitoring (SIBICC): With ICP monitors, stepwise escalation based on ICP thresholds (18–22 mmHg), waveform analysis, and cerebral autoregulation monitoring is advocated, allowing precise adjustment of therapy intensity, including hyperosmolar agents, deep sedation, and MAP challenges.
6. Neuromonitoring Techniques: Noninvasive and invasive neuromonitoring devices, such as transcranial Doppler ultrasonography (TCD), optic nerve sheath diameter (ONSD), quantitative pupillometry, brain tissue oxygen tension (PbtO₂), and cerebral microdialysis, provide vital bedside information to refine therapy further.
7. Cerebral Autoregulation Monitoring: Continuous cerebral autoregulation monitoring using pressure reactivity index (PRx) allows individualized optimization of CPP targets, potentially improving outcomes by maintaining CPP within autoregulation thresholds.
8. Brain Tissue Oxygenation (PbtO₂) Monitoring: PbtO₂ monitoring evaluates cerebral oxygen balance, guiding therapy aimed at correcting cerebral hypoxia through hemodynamic optimization and careful ventilation strategies, though definitive outcome benefits remain under investigation.
9. Future Research Directions: Further research is essential to define intervention protocols clearly, standardize neuromonitoring practices, and integrate advanced monitoring technologies into routine care effectively, aiming to enhance outcomes across diverse clinical settings.
10. Clinical Recommendations and Framework: The review outlines a structured framework for managing ICP crises, advocating ICP and advanced neuromonitoring use whenever feasible, while emphasizing alternative monitoring strategies in resource-limited settings to achieve optimal patient outcomes.

Conclusion:

Effective ICP crisis management involves comprehensive critical care, precise monitoring, and timely escalation of therapeutic interventions. While ICP monitoring remains the gold standard, noninvasive neuromonitoring methods are valuable in limited-resource scenarios, ensuring timely and individualized patient care to optimize neurological outcomes.

ACCESS FULL ARTICLE HERE

Watch the following video on “Management of raised Intra-Cranial Pressure” by Critical Care Cape Town

Discussion Questions:

1. How can advanced neuromonitoring techniques be practically integrated into existing clinical protocols, especially in resource-limited settings?
2. Which specific patient populations might benefit most significantly from routine implementation of cerebral autoregulation and PbtO₂ monitoring?
3. What further research is necessary to clarify the efficacy of various ICP-lowering interventions, such as mild hypothermia and barbiturate coma, in diverse clinical scenarios?

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.